Tsart Trio 6.25 Tablet

Tsart Trio 6.25 Tablet is a combination of three medicines: Telmisartan, Cilnidipine and Chlorthalidone. Telmisartan is an angiotensin receptor blocker (ARB) and Cilnidipine is a calcium channel blocker (CCB). They work by widening and relaxing the blood vessels, thereby lowering blood pressure. Chlorthalidone is a diuretic which removes extra water and certain electrolytes from the body through urine. Over time it also works by relaxing blood vessels and improving blood flow.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tsart Trio 6.25 Tablet is to be taken with food.

• Ankle swelling
• Headache
• Dizziness
• Tiredness
• Palpitations
• Sleepiness
• Increased blood uric acid
• Glucose intolerance
• Taste change
• Flushing (sense of warmth in the face, ears, neck and trunk)
• Stomach upset
• Altered blood lipids

Most side effects do not need medical attention and go away as your body adjusts. Talk to your doctor if they bother you or do not go away.

Alcohol Ask your doctor

Taking Chlorthalidone with alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.

Pregnancy Unsafe

Tsart Trio 6.25 Tablet is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

Breastfeeding Ask your doctor

No information is available on the use of Tsart Trio 6.25 Tablet during lactation. Please consult your doctor.

Driving Caution

Tsart Trio 6.25 Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.

Kidney Caution

Tsart Trio 6.25 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Tsart Trio 6.25 Tablet may be needed. Please consult your doctor. Use of Tsart Trio 6.25 Tablet is not recommended in these patients.

Liver Caution

Tsart Trio 6.25 Tablet should be used with caution in patients with liver disease. Dose adjustment of Tsart Trio 6.25 Tablet may be needed. Please consult your doctor. Use of Tsart Trio 6.25 Tablet is not recommended in patients with severe liver disease.